|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 471/04 | (2006.01) |
| A61K 9/0019 | (2013.01) | ||
| C07D 405/14 | (2006.01) | ||
| A61K 45/06 | (2013.01) | ||
| A61K 31/4525 | (2013.01) | ||
| A61K 31/4439 | (2006.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61K 9/00 | (2006.01) | ||
| A61K 31/4525 | (2006.01) | ||
| A61K 39/3955 | (2013.01) | ||
| A61K 39/395 | (2006.01) | ||
| C07K 16/2818 | (2013.01) | ||
| A61K 45/06 | (2006.01) | ||
| C07K 16/2827 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61K2039/505 | (2013.01) | ||
| C07K 16/28 | (2006.01) | ||
| A61K2039/545 | (2013.01) | ||
| A61K 39/00 | (2006.01) | ||
| C07K2317/21 | (2013.01) | ||
| C07K2317/73 | (2013.01) |
| (11) | Number of the document | 3551629 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17879038.2 |
| Date of filing the European patent application | 2017-12-08 | |
| (97) | Date of publication of the European application | 2019-10-16 |
| (45) | Date of publication and mention of the grant of the patent | 2023-11-15 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2017/065270 |
| Date | 2017-12-08 |
| (87) | Number | WO 2018/107004 |
| Date | 2018-06-14 |
| (30) | Number | Date | Country code |
| 201662497949 P | 2016-12-08 | US | |
| 201762465001 P | 2017-02-28 | US | |
| 201762545373 P | 2017-08-14 | US |
| (72) |
KOVACH, John S. , US
ZHUANG, Zhengping , US
HO, Sze Chun Winson , US
WANG, Herui , US
LU, Rongze , US
|
| (73) |
Lixte Biotechnology, Inc. ,
680 E. Colorado Blvd., Suite 180, Pasadena, CA 91101,
US
The U.S.A. as represented by the Secretary, Department of Health and Human Services , Office of Technology Transfer National Institutes of Health 6701 Rockledge Drive, Suite 700, Bethesda, MD 20892, US |
| (54) | OXABICYCLOHEPTANES FOR MODULATION OF IMMUNE RESPONSE |
| OXABICYCLOHEPTANES FOR MODULATION OF IMMUNE RESPONSE |